All participants were clinically normal at baseline, but the subgroup of individuals with high Aβ with fast tau increase met clinical criteria for MCI at follow-up.17 Our results indicate a sequence of observable phenomena in preclinical AD:. Here, MAPT is linked to Alzheimer disease.